Clinical Trial Update: Pilot Study of PHOENIX Wound Matrix® Impact on Chronic DFU Wound Microbiome [NA]

View source ↗

Summary

A pilot study completed to assess the impact of PHOENIX Wound Matrix on the wound microbiome in chronic diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• PHOENIX Wound Matrix

Snippet

Sponsor: RenovoDerm | Conditions: Diabetic Foot Ulcer | NA | Status: COMPLETED